Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: Analysis of serial marrow samples from normal donors

Bone Marrow Transplantation

Volumn 23, Issue 1, 1999, Pages 15-19

  Martinez C ^a   Urbano Ispizua, A ^b   Rozman, M ^b   Rovira, M ^b   Marin P ^b   Montfort, N ^b   Carreras, E ^b   Montserrat, E ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

Bone marrow CD34+ cells; G CSF; Normal donors

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; HLA DR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; NORMAL HUMAN; PRIORITY JOURNAL; STEADY STATE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0344527951     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701526     Document Type: Article

References (27)

1. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cell collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-3162.
2. Sheridan SP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilized by G-CSF (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-646.
3. Bensinger W, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
4. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
5. Gianni AM, Siena S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet 1989; 2: 580-588.
6. Dührsen U, Villeval JL, Boyd J et al. Effects of recombinant granulocyte colony-stimulating factor on hemopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074-2081.
7. Dreger P, Haferlach T, Eckestein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
8. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 25-31.
9. Anderlini P, Przepiorka D, Champlin R et al. Biological and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996; 88: 2819-2825.
10. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905-1914.
11. Stoppa AM, Biaise D, Viens P et al. Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous BM transplantation. Bone Marrow Transplant 1994; 13: 541-547.
12. Hansen PB, Knudsen H, Gaarsdal E et al. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability. Bone Marrow Transplant 1995; 16: 373-379.
13. Janssen WE, Smilee RC, Elfenbein GJ. A prospective randomized trial comparing blood- and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy. J Hematother 1995; 4: 139-140.
14. Damiani D, Fanin R, Silvestri F et al. Randomized trial of autologous G-CSF-primed bone marrow transplantation vs G-CSF-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 1997; 90: 36-42.
15. Dicke KA, Deborah LH, Hood L et al. Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting. Exp Hematol 1997; 25: 34-38.
16. Johnsen HE, Hansen PB, Plesner T et al. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1992; 10: 229-234.
17. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 1997; 89: 1189-1196.
18. Isola LM, Scigliano E, Skerrett D et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997; 20: 1033-1037.
19. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705-4709.
20. Urbano-Ispizua A, García-Conde J, Brunet S et al. High incidence of chronic GVHD after allogeneic peripheral blood progenitor cell transplantation from matched related donors. Haematologica 1997; 82: 683-689.
21. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA 1997; 94: 1908-1913.
22. Haas R, Möhle R, Pförsich M et al. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells. Blood 1995; 85: 1936-1943.
23. Atkinson K, Fay K, Nivison-Smith I, Downs K. Lenograstim administration to HLA-identical donor-recipient pairs to accelerate marrow recovery post-transplant. Bone Marrow Transplant 1997; 19: 15-21.
24. Bodine DM, Seidel EN, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 1996; 88: 89-97.
25. Mandalam RK, Vento CA, Stiff PJ et al. Stem and progenitor cell content and ex vivo expansion potential of human bone marrow primed in vivo with G-CSF. Blood 1997; 90 (Suppl. 2); 344 (Abstr. 4295).
26. de Haan G, Dontje B, Engel C et al. The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. Blood 1995; 86: 2986-2992.
27. + cell content but is associated with delayed pancytopenia. Bone Marrow Transplant 1998; 21: 431-440.